Vivoryon Therapeutics NV
F:05Y
Vivoryon Therapeutics NV
F:05Y
Price:
1.15
EUR
9%
Market Closed
Market Cap:
€30m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Vivoryon Therapeutics NV
F:05Y
|
DE |
|
G
|
Guangdong Investment Ltd
XMUN:GUG
|
HK |
|
G
|
Green Brick Partners Inc
SWB:2G1
|
US |
|
Sigma Healthcare Ltd
ASX:SIG
|
AU |
|
C
|
Colgate-Palmolive Co
XBER:CPA
|
US |
|
A
|
Aurubis AG
F:NDA
|
DE |
|
U
|
UniCredit SpA
OTC:UNCRY
|
IT |
|
I
|
Interface Inc
F:IF6N
|
US |
|
K
|
Kulicke and Soffa Industries Inc
XBER:KU1
|
SG |
|
B
|
Biogen Inc
DUS:IDP
|
US |
|
Kao Corp
F:KAO
|
JP |
|
T
|
Tsakos Energy Navigation Ltd
F:TK41
|
GR |
|
A
|
AXA SA
XHAM:AXA
|
FR |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
DUS:BOY
|
ES |
|
Keyence Corp
TSE:6861
|
JP |
|
Wheaton Precious Metals Corp
TSX:WPM
|
CA |
|
I
|
Interpublic Group of Companies Inc
F:IPG
|
US |
|
M
|
MultiChoice Group Ltd
SWB:30R
|
ZA |
|
A
|
ArcelorMittal SA
MAD:MTS
|
LU |
|
M
|
Microsoft Corp
XHAM:MSF
|
US |
|
Easterly Government Properties Inc
F:E050
|
US |
|
M
|
McCormick & Company Inc
LSE:0JZS
|
US |
|
P
|
Prosus NV
OTC:PROSY
|
NL |
DCF Valuation
is not available for Vivoryon Therapeutics NV
is not available for Vivoryon Therapeutics NV
05Y's DCF value cannot be reliably calculated.
Switch to
Continue 05Y Research
Other Vivoryon Therapeutics NV listings:
Discover More
